Research map: Cost-utility and budget impact analysis of herpes zoster vaccines in Thai patients with end-stage renal disease

Back to the article

Papers in this map

  1. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults · Himal Lal · 2015 · 1458 citations · Cited by this paper
  2. Effectiveness of person-centred versus usual care in elderly patients: findings from a multicentre randomised controlled trial · 2026 · Related
  3. Immune cell dysfunction and inflammation in end-stage renal disease · Michiel G.H. Betjes · 2013 · 558 citations · Cited by this paper
  4. Use of intravenous antibiotics for the management of suspected chorioamnionitis: insights from women's wellness and research center · 2026 · Related
  5. The global epidemiology of herpes zoster · Barbara P. Yawn · 2013 · 353 citations · Cited by this paper
  6. The impact of China’s National Drug Centralized Procurement Policy on pharmaceutical firm innovation: evidence from a staggered difference-in-differences analysis · 2026 · Related
  7. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study · Mélanie Drolet · 2010 · 317 citations · Cited by this paper
  8. The Saudi FDA drug evaluation timeline in comparison with international counterparts: a retrospective observational study · 2026 · Related
  9. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009–2014 · Cintia Muñoz-Quiles · 2020 · 106 citations · Cited by this paper
  10. Community pharmacy based point-of-care testing for early detection of undiagnosed type 2 diabetes mellitus: a study protocol · 2026 · Related
  11. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000–2012 · Emad A. Yanni · 2018 · 85 citations · Cited by this paper
  12. Landscape of national antibiotic utilisation in Malaysia: an analysis of national pharmaceutical sales data from 2019 to 2023 · 2026 · Related
  13. Recurrence Rate of Herpes Zoster and Its Risk Factors: a Population-based Cohort Study · You Jeong Kim · 2018 · 75 citations · Cited by this paper
  14. Reconstructing the professional role of pharmacists in China from the perspective of public value theory: challenges and institutional pathways · 2026 · Related
  15. Efficacy, effectiveness, and safety of herpes zoster vaccine in the immunocompetent and immunocompromised subjects: A systematic review and network meta-analysis · Yue Xia · 2022 · 69 citations · Cited by this paper
  16. Economic burden and health utility of transfusion-dependent beta-thalassemia in Thai adults: a societal perspective · 2026 · Related
  17. Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies · Delwyn Zhi Jie Lim · 2024 · 64 citations · Cited by this paper
  18. A scoping review of the views and experiences of health professionals in the Middle East and North Africa regions regarding social media use · 2026 · Related
  19. Risk of Herpes Zoster in Patients Treated With Long-term Hemodialysis: A Matched Cohort Study · Chien-Chun Kuo · 2011 · 57 citations · Cited by this paper
  20. Development and validation of the 9-item Patient Satisfaction Questionnaire (PSQ-9) for use in community pharmacy settings · 2026 · Related
  21. Cost-Effectiveness of Herpes Zoster Vaccine for Persons Aged 50 Years · Phuc Nhan Bao Le · 2015 · 53 citations · Cited by this paper
  22. Effectiveness of Herpes Zoster Vaccine in Patients 60 Years and Older With End-stage Renal Disease · Hung Fu Tseng · 2015 · 49 citations · Cited by this paper
  23. Measuring herpes zoster, zoster‐associated pain, post‐herpetic neuralgia‐associated loss of quality of life, and healthcare utilization and costs in Thailand · Kobkul Aunhachoke · 2011 · 39 citations · Cited by this paper
  24. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006–2015 · Elaine R. Miller · 2018 · 34 citations · Cited by this paper
  25. Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) · Paolo Pedrazzoli · 2022 · 33 citations · Cited by this paper
  26. Survival Analysis and Associated Factors in THAI Patients on Peritoneal Dialysis under the PD-First Policy · Siribha Changsirikulchai · 2018 · 28 citations · Cited by this paper
  27. Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review · Filippo Ansaldi · 2016 · 27 citations · Cited by this paper
  28. Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations · Fawziah Marra · 2024 · 26 citations · Cited by this paper
  29. Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data · Jennifer C. Nelson · 2022 · 25 citations · Cited by this paper
  30. Patient-reported quality of life in patients suffering from acute herpes zoster—a systematic review with meta-analysis · Martin Sollie · 2022 · 22 citations · Cited by this paper
  31. Hepatitis B virus vaccine and chronic kidney disease. The advances · Fabrizio Fabrizi · 2021 · 18 citations · Cited by this paper
  32. Mortality risk after herpes zoster infection in end-stage renal disease patients · John H Ahn · 2018 · 15 citations · Cited by this paper
  33. Trends in influenza and pneumococcal vaccine coverage in Thai patients with type 2 diabetes mellitus 2010–2018: Experience from a tertiary diabetes center in Bangkok · Yotsapon Thewjitcharoen · 2020 · 13 citations · Cited by this paper
  34. Prevalence and Management of Chronic Pain, Including Neuropathic Pain, in Dialysis Patients with End-Stage Renal Disease · Klaudia Kitala–Tańska · 2024 · 11 citations · Cited by this paper
  35. Cost-effectiveness and budget impact analyses for the prioritisation of the four available rotavirus vaccines in the national immunisation programme in Thailand · Nantasit Luangasanatip · 2021 · 10 citations · Cited by this paper
  36. PRM3 Standard Cost List for Economic Evaluation in Thailand · Arthorn Riewpaiboon · 2012 · 8 citations · Cited by this paper
  37. Recombinant Varicella Zoster vaccine in haemodialysis facilities: adherence and safety · Francesca Katiana Martino · 2023 · 8 citations · Cited by this paper
  38. Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States · Ahmed Salem · 2023 · 8 citations · Cited by this paper
  39. Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy · Lucy R Williams · 2025 · 8 citations · Cited by this paper

Source: OpenAlex (CC0)